We are live on ! Find out more
TCM

Tamarack Capital Management Portfolio holdings

AUM $840M
1-Year Est. Return 19.47%
This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+19.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$451M
AUM Growth
-$38.8M
Cap. Flow
-$25.2M
Cap. Flow %
-5.59%
Top 10 Hldgs %
66.12%
Holding
39
New
10
Increased
13
Reduced
5
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$23.5M
2
ELGX
Endologix Inc
ELGX
+$12.9M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$7.94M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$7.23M
5
PDCO
Patterson Companies, Inc.
PDCO
+$5.79M

Top Sells

Rank Stock Value
1
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$21.1M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$20.5M
3
CFN
CAREFUSION CORPORATION
CFN
+$16.9M
4
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$13M
5
AEGR
Aegerion Pharmaceuticals
AEGR
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 56.27%
2 Technology 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
26
Becton Dickinson
BDX
$46.9B
$4.55M 1.01%
+41,000
New +$4.68M
DXCM icon
27
DexCom
DXCM
$32.9B
$4.2M 0.93%
+420,000
New +$4.29M
HNGR
28
DELISTED
Hanger Inc.
HNGR
$4.1M 0.91%
+200,000
New +$5.1M
CORI
29
DELISTED
Corium International, Inc.
CORI
$4.1M 0.91%
667,579
+39,909
+6% +$266K
WINT
30
DELISTED
Windtree Therapeutics Inc
WINT
$2.76M 0.61%
107,143
– –
CNMD icon
31
CALL
CONMED
CNMD
$1.55B
– –
-5,200
Closed -$227K
CNMD icon
32
CONMED
CNMD
$1.55B
– –
-50,000
Closed -$2.18M
IRWD icon
33
Ironwood Pharmaceuticals
IRWD
$728M
– –
-955,200
Closed -$11.5M
IWM icon
34
PUT
iShares Russell 2000 ETF
IWM
$81.5B
– –
-1,100,000
Closed -$128M
VCRA
35
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-700,000
Closed -$9.19M
AMAG
36
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-64,080
Closed -$1.22M
AEGR
37
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-400,000
Closed -$11.7M
CTRX
38
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
– –
-300,000
Closed -$13M
COV
39
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-225,000
Closed -$20.5M
1
2

Similar funds

RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return
CWA
Constellation Wealth Advisors New York $903M AUM 2.38% 1-Year Est. Return
GHF
Good Harbor Financial Barrington, Illinois $916M AUM 5.96% 1-Year Est. Return
F
FutureAdvisor San Francisco, California $617M AUM 6.57% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
BMCMI
Bryn Mawr Capital Management Inc Bryn Mawr, Pennsylvania $577M AUM 6.5% 1-Year Est. Return
GACM
Green Arrow Capital Management New York $535M AUM 14.21% 1-Year Est. Return
AH
Achievement Holdings Chicago, Illinois $1.2B AUM 9.2% 1-Year Est. Return

Tamarack Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Tamarack Capital Management held 39 positions worth $451M, down 7.9% from $490M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Tamarack Capital Management withdrew a net $25.2M in Q3 2014, closing 9 positions and reducing 5 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $20.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 50% a quarter earlier, followed by Technology.

Against the trend, Tamarack Capital Management opened a new position in Medtronic worth $22.9M.

  • Tamarack Capital Management's largest Q3 2014 buy was Medtronic: 370,000 shares worth $22.9M.
  • Tamarack Capital Management added most to Endologix Inc in Q3 2014, an estimated $12.9M increase.
  • Tamarack Capital Management's biggest Q3 2014 reduction was VOLCANO CORPORATION COM STK, cutting an estimated $21.1M.
  • Tamarack Capital Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014, selling an estimated $20.5M.
  • Tamarack Capital Management's ten largest holdings make up 66% of its $451M portfolio in Q3 2014.
  • Tamarack Capital Management opened 10 new positions and closed 9 in Q3 2014.
  • Tamarack Capital Management's portfolio value fell 7.9% quarter-over-quarter to $451M.

Based on Tamarack Capital Management's 13F filing for Q3 2014, filed 7 Nov 2014.